首页 > 最新文献

ISRN endocrinology最新文献

英文 中文
Four Hour Temporal Relation of 5-HTP and L-DOPA Induces Inhibitory Responses in Recrudescing Gonad of Indian Palm Squirrel (Funambulus pennantii). 5-HTP和L-DOPA的4小时时间关系诱导棕榈松鼠生殖腺再生的抑制反应。
Pub Date : 2013-07-01 Print Date: 2013-01-01 DOI: 10.1155/2013/206876
Ranjana Jaiwal, C M Chaturvedi

Daily injections of L-dihydroxyphenylalanine (L-DOPA, dopamine precursor) given 4 h after 5-hydroxytryptophan (5-HTP, serotonin precursor) induced inhibitory responses in recrudescing gonad (in the first week of December) of Indian palm squirrel, a seasonally breeding subtropical animal. Other temporal relations (L-DOPA given at 0, 8, 12, 16, and 20 h after 5-HTP administration) did not show any effect on the recrudescing gonad. This inhibitory effect of 4 h was evident under short day length (6 : 18) group but was masked by the increasing day length of nature (NDL, late December onwards) and increased photoperiod of long day group (16 : 8). It is apparent that seasonal testicular recrudescence of Indian palm squirrel during short day length by 4 h relation of 5-HTP and L-DOPA is not a pharmacological effect but actually is an alteration of seasonality in this annually breeding mammal. It seems that endogenous mechanism controlling seasonal testicular recrudescence of Indian palm squirrel is reset by timed daily injections of these neurotransmitter drugs. It is suggested that in spite of different environmental factors (photoperiod, humidity, etc.) used by different species to time their annual reproduction, basic mechanism of seasonality appears to be the same, that is, the temporal synergism of neurotransmitter activity.

5-羟色氨酸(5-HTP, 5-羟色胺前体)诱导亚热带季节性繁殖动物印度棕榈松鼠(12月第一周)性腺复发抑制反应后4小时,每日注射l -二羟苯丙氨酸(L-DOPA,多巴胺前体)。其他时间关系(在5-羟色胺给药后0、8、12、16和20小时给予左旋多巴)对性腺的复发没有任何影响。这种4 h的抑制作用在短日照组(6:18)表现明显,但被白昼长度的增加(NDL, 12月下旬起)和长日照组(16:8)的增加所掩盖。从5-HTP和L-DOPA 4 h的关系可以看出,棕松鼠在短日长期间的季节性睾丸复发不是一种药理作用,而实际上是这种每年繁殖的哺乳动物的季节性改变。似乎控制印度棕榈松鼠睾丸季节性复发的内源性机制是通过定时每日注射这些神经递质药物来重置的。这表明,尽管不同物种利用不同的环境因子(光周期、湿度等)来确定其每年繁殖的时间,但季节性的基本机制似乎是相同的,即神经递质活性的时间协同作用。
{"title":"Four Hour Temporal Relation of 5-HTP and L-DOPA Induces Inhibitory Responses in Recrudescing Gonad of Indian Palm Squirrel (Funambulus pennantii).","authors":"Ranjana Jaiwal,&nbsp;C M Chaturvedi","doi":"10.1155/2013/206876","DOIUrl":"https://doi.org/10.1155/2013/206876","url":null,"abstract":"<p><p>Daily injections of L-dihydroxyphenylalanine (L-DOPA, dopamine precursor) given 4 h after 5-hydroxytryptophan (5-HTP, serotonin precursor) induced inhibitory responses in recrudescing gonad (in the first week of December) of Indian palm squirrel, a seasonally breeding subtropical animal. Other temporal relations (L-DOPA given at 0, 8, 12, 16, and 20 h after 5-HTP administration) did not show any effect on the recrudescing gonad. This inhibitory effect of 4 h was evident under short day length (6 : 18) group but was masked by the increasing day length of nature (NDL, late December onwards) and increased photoperiod of long day group (16 : 8). It is apparent that seasonal testicular recrudescence of Indian palm squirrel during short day length by 4 h relation of 5-HTP and L-DOPA is not a pharmacological effect but actually is an alteration of seasonality in this annually breeding mammal. It seems that endogenous mechanism controlling seasonal testicular recrudescence of Indian palm squirrel is reset by timed daily injections of these neurotransmitter drugs. It is suggested that in spite of different environmental factors (photoperiod, humidity, etc.) used by different species to time their annual reproduction, basic mechanism of seasonality appears to be the same, that is, the temporal synergism of neurotransmitter activity. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"206876"},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/206876","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31650023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Autoimmune thyroid disorders. 自身免疫性甲状腺疾病。
Pub Date : 2013-06-26 Print Date: 2013-01-01 DOI: 10.1155/2013/509764
M A Iddah, B N Macharia

Purpose of Review. Studies have been published in the field of autoimmune thyroid diseases since January 2005. The review is organized into areas of etiology, autoimmune features, autoantibodies, mechanism of thyroid cell injury, B-cell responses, and T-cell responses. Also it reviews the diagnosis and the relationship between autoimmune thyroid disease, neoplasm, and kidney disorders. Recent Findings. Autoimmune thyroid diseases have been reported in people living in different parts of the world including North America, Europe, Baalkans, Asia, Middle East, South America, and Africa though the reported figures do not fully reflect the number of people infected per year. Cases are unrecognized due to inaccurate diagnosis and hence are treated as other diseases. However, the most recent studies have shown that the human autoimmune thyroid diseases (AITDs) affect up to 5% of the general population and are seen mostly in women between 30 and 50 years. Summary. Autoimmune thyroid disease is the result of a complex interaction between genetic and environmental factors. Overall, this review has expanded our understanding of the mechanism involved in pathogenesis of AITD and the relationship between autoimmune thyroid disease, neoplasm, and kidney disease. It has opened new lines of investigations that will ultimately result in a better clinical practice.

审查的目的。自2005年1月以来,在自身免疫性甲状腺疾病领域发表了研究报告。综述分为病原学、自身免疫特征、自身抗体、甲状腺细胞损伤机制、b细胞反应和t细胞反应等领域。同时对自身免疫性甲状腺疾病、肿瘤和肾脏疾病的诊断和关系进行综述。最近的发现。据报道,生活在世界不同地区的人都患有自身免疫性甲状腺疾病,包括北美、欧洲、巴尔干半岛、亚洲、中东、南美和非洲,但报告的数字并不能完全反映每年感染的人数。由于诊断不准确,病例无法被识别,因此被当作其他疾病对待。然而,最近的研究表明,人类自身免疫性甲状腺疾病(AITDs)影响到总人口的5%,主要发生在30至50岁的女性中。总结。自身免疫性甲状腺疾病是遗传和环境因素复杂相互作用的结果。总之,这篇综述扩大了我们对AITD发病机制的理解,以及自身免疫性甲状腺疾病、肿瘤和肾脏疾病之间的关系。它开辟了新的研究路线,最终将导致更好的临床实践。
{"title":"Autoimmune thyroid disorders.","authors":"M A Iddah,&nbsp;B N Macharia","doi":"10.1155/2013/509764","DOIUrl":"https://doi.org/10.1155/2013/509764","url":null,"abstract":"<p><p>Purpose of Review. Studies have been published in the field of autoimmune thyroid diseases since January 2005. The review is organized into areas of etiology, autoimmune features, autoantibodies, mechanism of thyroid cell injury, B-cell responses, and T-cell responses. Also it reviews the diagnosis and the relationship between autoimmune thyroid disease, neoplasm, and kidney disorders. Recent Findings. Autoimmune thyroid diseases have been reported in people living in different parts of the world including North America, Europe, Baalkans, Asia, Middle East, South America, and Africa though the reported figures do not fully reflect the number of people infected per year. Cases are unrecognized due to inaccurate diagnosis and hence are treated as other diseases. However, the most recent studies have shown that the human autoimmune thyroid diseases (AITDs) affect up to 5% of the general population and are seen mostly in women between 30 and 50 years. Summary. Autoimmune thyroid disease is the result of a complex interaction between genetic and environmental factors. Overall, this review has expanded our understanding of the mechanism involved in pathogenesis of AITD and the relationship between autoimmune thyroid disease, neoplasm, and kidney disease. It has opened new lines of investigations that will ultimately result in a better clinical practice. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"509764"},"PeriodicalIF":0.0,"publicationDate":"2013-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/509764","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31601103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 72
Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus. 波兰系统性红斑狼疮患者维生素D受体基因BsmI多态性
Pub Date : 2013-06-18 Print Date: 2013-01-01 DOI: 10.1155/2013/427818
Beata Kaleta, Jarosław Bogaczewicz, Ewa Robak, Anna Sysa-Jędrzejowska, Małgorzata Wrzosek, Weronika Szubierajska, Piotr Mróz, Jacek Lukaszkiewicz, Anna Woźniacka

The hormonally active form of vitamin D3, 1,25(OH)2D3 (calcitriol), exerts actions through VDR receptor, which acts as a transcriptional factor. Calcitriol is an immunomodulator that affects various immune cells, and several studies link it to many autoimmune diseases. BsmI polymorphism affects the level of VDR gene transcription, transcript stability, and posttranscriptional modifications. It seems to be related to the systemic lupus erythematosus (SLE). Our study examined the characteristics of VDR gene BsmI polymorphism in Polish SLE patients and their relationship with clinical manifestations of the disease. We genotyped 62 patients with SLE and 100 healthy controls using the real-time PCR. There were no differences observed in the frequency of BsmI genotypes in SLE patients and in the control group. There was no significant correlation between BsmI genotypes and clinical symptoms of SLE, but the AA genotype correlates with higher levels of antinuclear antibodies (ANA) in this group (r = 0.438; P = 0.002). A larger study examining BsmI and other VDR gene polymorphisms is needed. It may allow explaining differences in the clinical picture of the disease and choosing a personalized therapy.

维生素D3的激素活性形式,1,25(OH)2D3(骨化三醇),通过作为转录因子的VDR受体发挥作用。骨化三醇是一种影响多种免疫细胞的免疫调节剂,一些研究将其与许多自身免疫性疾病联系起来。BsmI多态性影响VDR基因的转录水平、转录稳定性和转录后修饰。它似乎与系统性红斑狼疮(SLE)有关。我们的研究探讨了波兰SLE患者VDR基因BsmI多态性的特征及其与疾病临床表现的关系。我们使用实时PCR对62例SLE患者和100例健康对照进行基因分型。在SLE患者和对照组中,BsmI基因型的频率没有差异。BsmI基因型与SLE临床症状无显著相关性,但AA基因型与该组患者较高水平的抗核抗体(ANA)相关(r = 0.438;P = 0.002)。需要对BsmI和其他VDR基因多态性进行更大规模的研究。它可以解释疾病临床表现的差异,并选择个性化的治疗方法。
{"title":"Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus.","authors":"Beata Kaleta,&nbsp;Jarosław Bogaczewicz,&nbsp;Ewa Robak,&nbsp;Anna Sysa-Jędrzejowska,&nbsp;Małgorzata Wrzosek,&nbsp;Weronika Szubierajska,&nbsp;Piotr Mróz,&nbsp;Jacek Lukaszkiewicz,&nbsp;Anna Woźniacka","doi":"10.1155/2013/427818","DOIUrl":"https://doi.org/10.1155/2013/427818","url":null,"abstract":"<p><p>The hormonally active form of vitamin D3, 1,25(OH)2D3 (calcitriol), exerts actions through VDR receptor, which acts as a transcriptional factor. Calcitriol is an immunomodulator that affects various immune cells, and several studies link it to many autoimmune diseases. BsmI polymorphism affects the level of VDR gene transcription, transcript stability, and posttranscriptional modifications. It seems to be related to the systemic lupus erythematosus (SLE). Our study examined the characteristics of VDR gene BsmI polymorphism in Polish SLE patients and their relationship with clinical manifestations of the disease. We genotyped 62 patients with SLE and 100 healthy controls using the real-time PCR. There were no differences observed in the frequency of BsmI genotypes in SLE patients and in the control group. There was no significant correlation between BsmI genotypes and clinical symptoms of SLE, but the AA genotype correlates with higher levels of antinuclear antibodies (ANA) in this group (r = 0.438; P = 0.002). A larger study examining BsmI and other VDR gene polymorphisms is needed. It may allow explaining differences in the clinical picture of the disease and choosing a personalized therapy. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"427818"},"PeriodicalIF":0.0,"publicationDate":"2013-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/427818","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31580072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Routine Screening for Cushing's Syndrome Is Not Required in Patients Presenting with Obesity. 肥胖患者不需要常规筛查库欣综合征。
Pub Date : 2013-06-11 Print Date: 2013-01-01 DOI: 10.1155/2013/321063
Serap Baydur Sahin, Hacer Sezgin, Teslime Ayaz, Emine Uslu Gur, Kadir Ilkkilic

Background. Cushing's syndrome (CS) is a relatively unusual condition that resembles many of the phenotypic features of obesity. Our aim was to evaluate the frequency of CS in obese patients. Materials and Methods. This study included 354 consecutive patients (87.9% female, age 37.8 ± 13.4 years) who presented with simple obesity. All the patients were evaluated for the clinical signs of CS. Lipid parameters, fasting glucose (FPG) and insulin, 75 gr oral glucose tolerance test, basal cortisol and ACTH were measured. 1 mg overnight DST was performed. Results. The mean weight of the patients was 102.4 ± 20.1 kg and BMI 40 ± 7.35 kg/m(2). 34.5% of the patients were hypertensive. 36.2% of the patients had central obesity, 72% dorsocervical fat accumulation, 28.8% abdominal striae and 23.2% acne. 49.4% of the women had hirsutism. 46.5% had prediabetes and 12.0% had type 2 diabetes, 72.6% had dyslipidemia. The mean cortisol and ACTH levels were as follows: 9.28 ± 3.53  μ g/dL and 17.02 ± 10.43 pg/mL. Seven patients failed to suppress plasma cortisol to less than 1.8  μ g/dL. Biochemical confirmation tests were performed in these patients and 2 of them were diagnosed glucocorticoid-secreting adrenal adenoma. Conclusions. Routine screening for CS in obese patients is not required.

背景。库欣综合征(CS)是一种相对罕见的疾病,与肥胖的许多表型特征相似。我们的目的是评估肥胖患者发生CS的频率。材料与方法。本研究纳入354例单纯性肥胖患者(87.9%为女性,年龄37.8±13.4岁)。评估所有患者CS的临床症状。测定血脂参数、空腹血糖(FPG)、胰岛素、75 gr口服糖耐量、基础皮质醇、ACTH。1 mg彻夜DST。结果。患者平均体重102.4±20.1 kg, BMI 40±7.35 kg/m(2)。34.5%为高血压。中心性肥胖占36.2%,颈背脂肪堆积占72%,腹部纹占28.8%,痤疮占23.2%。49.4%的女性有多毛症。糖尿病前期46.5%,2型糖尿病12.0%,血脂异常72.6%。皮质醇和ACTH的平均水平分别为9.28±3.53 μ g/dL和17.02±10.43 pg/mL。7例患者未能将血浆皮质醇抑制至1.8 μ g/dL以下。其中2例诊断为肾上腺糖皮质激素分泌腺瘤。结论。不需要对肥胖患者进行CS常规筛查。
{"title":"Routine Screening for Cushing's Syndrome Is Not Required in Patients Presenting with Obesity.","authors":"Serap Baydur Sahin,&nbsp;Hacer Sezgin,&nbsp;Teslime Ayaz,&nbsp;Emine Uslu Gur,&nbsp;Kadir Ilkkilic","doi":"10.1155/2013/321063","DOIUrl":"https://doi.org/10.1155/2013/321063","url":null,"abstract":"<p><p>Background. Cushing's syndrome (CS) is a relatively unusual condition that resembles many of the phenotypic features of obesity. Our aim was to evaluate the frequency of CS in obese patients. Materials and Methods. This study included 354 consecutive patients (87.9% female, age 37.8 ± 13.4 years) who presented with simple obesity. All the patients were evaluated for the clinical signs of CS. Lipid parameters, fasting glucose (FPG) and insulin, 75 gr oral glucose tolerance test, basal cortisol and ACTH were measured. 1 mg overnight DST was performed. Results. The mean weight of the patients was 102.4 ± 20.1 kg and BMI 40 ± 7.35 kg/m(2). 34.5% of the patients were hypertensive. 36.2% of the patients had central obesity, 72% dorsocervical fat accumulation, 28.8% abdominal striae and 23.2% acne. 49.4% of the women had hirsutism. 46.5% had prediabetes and 12.0% had type 2 diabetes, 72.6% had dyslipidemia. The mean cortisol and ACTH levels were as follows: 9.28 ± 3.53  μ g/dL and 17.02 ± 10.43 pg/mL. Seven patients failed to suppress plasma cortisol to less than 1.8  μ g/dL. Biochemical confirmation tests were performed in these patients and 2 of them were diagnosed glucocorticoid-secreting adrenal adenoma. Conclusions. Routine screening for CS in obese patients is not required. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"321063"},"PeriodicalIF":0.0,"publicationDate":"2013-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/321063","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31568398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Mouse models and techniques for the isolation of the diabetic endothelium. 糖尿病内皮细胞的小鼠模型和分离技术。
Pub Date : 2013-06-11 Print Date: 2013-01-01 DOI: 10.1155/2013/165397
April L Darrow, J Gregory Maresh, Ralph V Shohet

Understanding the molecular mechanisms underlying diabetic endothelial dysfunction is necessary in order to improve the cardiovascular health of diabetic patients. Previously, we described an in vivo, murine model of insulin resistance induced by feeding a high-fat diet (HFD) whereby the endothelium may be isolated by fluorescence-activated cell sorting (FACS) based on Tie2-GFP expression and cell-surface staining. Here, we apply this model to two new strains of mice, ScN/Tie2-GFP and ApoE(-/-)/Tie2-GFP, and describe their metabolic responses and endothelial isolation. ScN/Tie2-GFP mice, which lack a functional toll-like receptor 4 (TLR4), display lower fasting glucose and insulin levels and improved glucose tolerance compared to Tie2-GFP mice, suggesting that TLR4 deficiency decreases susceptibility to the development of insulin resistance. ApoE(-/-)/Tie2-GFP mice display elevated glucose and cholesterol levels versus Tie2-GFP mice. Endothelial isolation by FACS achieves a pure population of endothelial cells that retain GFP fluorescence and endothelial functions. Transcriptional analysis of the aortic and muscle endothelium isolated from ApoE(-/-)/Tie2-GFP mice reveals a reduced endothelial response to HFD compared to Tie2-GFP mice, perhaps resulting from preexisting endothelial dysfunction in the hypercholesterolemic state. These mouse models and endothelial isolation techniques are valuable for assessing diabetic endothelial dysfunction and vascular responses in vivo.

了解糖尿病内皮功能障碍的分子机制是改善糖尿病患者心血管健康的必要条件。先前,我们描述了高脂肪饮食(HFD)诱导的小鼠体内胰岛素抵抗模型,其中内皮可以通过基于Tie2-GFP表达和细胞表面染色的荧光激活细胞分选(FACS)分离。在这里,我们将该模型应用于两种新的小鼠,ScN/Tie2-GFP和ApoE(-/-)/Tie2-GFP,并描述了它们的代谢反应和内皮分离。与Tie2-GFP小鼠相比,缺乏功能性toll样受体4 (TLR4)的ScN/ tie - gfp小鼠表现出较低的空腹血糖和胰岛素水平,并改善了葡萄糖耐量,这表明TLR4缺乏降低了胰岛素抵抗的易感性。ApoE(-/-)/Tie2-GFP小鼠与Tie2-GFP小鼠相比,葡萄糖和胆固醇水平升高。通过FACS分离内皮细胞获得了保留GFP荧光和内皮功能的纯内皮细胞群。从ApoE(-/-)/ tie - gfp小鼠分离的主动脉和肌肉内皮的转录分析显示,与tie - gfp小鼠相比,内皮对HFD的反应降低,这可能是由于高胆固醇血症状态下预先存在的内皮功能障碍造成的。这些小鼠模型和内皮分离技术对评估糖尿病内皮功能障碍和血管反应有价值。
{"title":"Mouse models and techniques for the isolation of the diabetic endothelium.","authors":"April L Darrow,&nbsp;J Gregory Maresh,&nbsp;Ralph V Shohet","doi":"10.1155/2013/165397","DOIUrl":"https://doi.org/10.1155/2013/165397","url":null,"abstract":"<p><p>Understanding the molecular mechanisms underlying diabetic endothelial dysfunction is necessary in order to improve the cardiovascular health of diabetic patients. Previously, we described an in vivo, murine model of insulin resistance induced by feeding a high-fat diet (HFD) whereby the endothelium may be isolated by fluorescence-activated cell sorting (FACS) based on Tie2-GFP expression and cell-surface staining. Here, we apply this model to two new strains of mice, ScN/Tie2-GFP and ApoE(-/-)/Tie2-GFP, and describe their metabolic responses and endothelial isolation. ScN/Tie2-GFP mice, which lack a functional toll-like receptor 4 (TLR4), display lower fasting glucose and insulin levels and improved glucose tolerance compared to Tie2-GFP mice, suggesting that TLR4 deficiency decreases susceptibility to the development of insulin resistance. ApoE(-/-)/Tie2-GFP mice display elevated glucose and cholesterol levels versus Tie2-GFP mice. Endothelial isolation by FACS achieves a pure population of endothelial cells that retain GFP fluorescence and endothelial functions. Transcriptional analysis of the aortic and muscle endothelium isolated from ApoE(-/-)/Tie2-GFP mice reveals a reduced endothelial response to HFD compared to Tie2-GFP mice, perhaps resulting from preexisting endothelial dysfunction in the hypercholesterolemic state. These mouse models and endothelial isolation techniques are valuable for assessing diabetic endothelial dysfunction and vascular responses in vivo. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"165397"},"PeriodicalIF":0.0,"publicationDate":"2013-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/165397","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31568397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood. 人血清PCSK9在分娩时比未怀孕的人升高,而脐带血的血清PCSK9比母血低。
Pub Date : 2013-06-05 Print Date: 2013-01-01 DOI: 10.1155/2013/341632
Patricia Peticca, Angela Raymond, Andrée Gruslin, Marion Cousins, Ejibunmi Adetola, Hussein Abujrad, Janice Mayne, Teik Chye Ooi

Background. Serum lipids including total cholesterol (TC), triglycerides (TG), and low density lipoprotein cholesterol (LDL-C) are increased in pregnancy. Serum proprotein convertase subtilisin kexin 9 (PCSK9) is a significant player in lipoprotein metabolism. Circulating PCSK9 downregulates the LDL receptor on the surface of the liver, inhibiting clearance of LDL-C. Therefore, our study assessed serum PCSK9 concentrations at parturition (Maternal) compared to a nonpregnant (Control) cohort, as well as between mother and newborn (Maternal and Newborn). Methods. Blood was collected from women at parturition and from umbilical cords. Serum lipids and PCSK9 were measured and data were analysed for significance by Mann-Whitney U test at P < 0.05 and presented as median levels. Spearman's correlations were made at a 95% confidence interval. Results. Serum PCSK9 was significantly higher in Maternal versus Control cohorts (493.1 versus 289.7 ng/mL; P < 0.001, resp.), while the Newborn cohort was significantly lower than Maternal (278.2 versus 493.1 ng/mL; P < 0.0001, resp.). PCSK9 was significantly correlated with TC and HDL-C in Maternal and with TC, LDL-C, and HDL-C in Newborn cohorts. Conclusions. Our study provides the first quantitative report on PCSK9 in pregnancy (at parturition) and in umbilical cord blood. Further research will determine how these changes may affect lipoprotein levels during this physiological state.

背景。血清血脂包括总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)在怀孕期间升高。血清枯草杆菌蛋白转化酶9 (PCSK9)在脂蛋白代谢中起着重要作用。循环PCSK9下调肝脏表面LDL受体,抑制LDL- c的清除。因此,我们的研究评估了分娩时(母体)与非妊娠(对照)队列以及母亲与新生儿(母体和新生儿)之间的血清PCSK9浓度。方法。从分娩时的妇女和脐带中采集血液。测定血脂和PCSK9,采用Mann-Whitney U检验,P < 0.05,以中位数表示。Spearman相关在95%置信区间内。结果。母体组血清PCSK9显著高于对照组(493.1 ng/mL vs 289.7 ng/mL;P < 0.001, resp),而新生儿组显著低于产妇组(278.2 vs 493.1 ng/mL;P < 0.0001)。PCSK9与产妇TC和HDL-C显著相关,与新生儿TC、LDL-C和HDL-C显著相关。结论。我们的研究提供了PCSK9在妊娠(分娩)和脐带血中的第一个定量报告。进一步的研究将确定这些变化如何影响这种生理状态下的脂蛋白水平。
{"title":"Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood.","authors":"Patricia Peticca,&nbsp;Angela Raymond,&nbsp;Andrée Gruslin,&nbsp;Marion Cousins,&nbsp;Ejibunmi Adetola,&nbsp;Hussein Abujrad,&nbsp;Janice Mayne,&nbsp;Teik Chye Ooi","doi":"10.1155/2013/341632","DOIUrl":"https://doi.org/10.1155/2013/341632","url":null,"abstract":"<p><p>Background. Serum lipids including total cholesterol (TC), triglycerides (TG), and low density lipoprotein cholesterol (LDL-C) are increased in pregnancy. Serum proprotein convertase subtilisin kexin 9 (PCSK9) is a significant player in lipoprotein metabolism. Circulating PCSK9 downregulates the LDL receptor on the surface of the liver, inhibiting clearance of LDL-C. Therefore, our study assessed serum PCSK9 concentrations at parturition (Maternal) compared to a nonpregnant (Control) cohort, as well as between mother and newborn (Maternal and Newborn). Methods. Blood was collected from women at parturition and from umbilical cords. Serum lipids and PCSK9 were measured and data were analysed for significance by Mann-Whitney U test at P < 0.05 and presented as median levels. Spearman's correlations were made at a 95% confidence interval. Results. Serum PCSK9 was significantly higher in Maternal versus Control cohorts (493.1 versus 289.7 ng/mL; P < 0.001, resp.), while the Newborn cohort was significantly lower than Maternal (278.2 versus 493.1 ng/mL; P < 0.0001, resp.). PCSK9 was significantly correlated with TC and HDL-C in Maternal and with TC, LDL-C, and HDL-C in Newborn cohorts. Conclusions. Our study provides the first quantitative report on PCSK9 in pregnancy (at parturition) and in umbilical cord blood. Further research will determine how these changes may affect lipoprotein levels during this physiological state. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"341632"},"PeriodicalIF":0.0,"publicationDate":"2013-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/341632","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31586297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 26
Placental HSD2 Expression and Activity Is Unaffected by Maternal Protein Consumption or Gender in C57BL/6 Mice. C57BL/6小鼠胎盘HSD2的表达和活性不受母体蛋白摄入或性别的影响
Pub Date : 2013-05-28 Print Date: 2013-01-01 DOI: 10.1155/2013/867938
Mark R Garbrecht, Fred S Lamb
The placenta acts as a physiological barrier, preventing the transfer of maternal glucocorticoids to the developing fetus. This is accomplished via the oxidation, and subsequent inactivation, of endogenous glucocorticoids by the 11-β hydroxysteroid dehydrogenase type 2 enzyme (HSD2). Maternal protein restriction during pregnancy has been shown to result in a decrease in placental HSD2 expression and fetal glucocorticoid overexposure, especially late in gestation, resulting in low birth weight and “fetal programming” of the offspring. This dietary intervention impairs fetal growth and cardiovascular function in adult C57BL/6 offspring, but the impact on placental HSD2 has not been defined. The goal of the current study was to examine the effects of a maternal low-protein diet (18% versus 9% protein) on placental HSD2 gene expression and enzyme activity in mice during late gestation. In contrast to previous studies in rats, a maternal low-protein diet did not affect HSD2 protein or enzyme activity levels in the placentas of C57BL/6 mice and this was irrespective of the gender of the offspring. These data suggest that the effects of maternal protein restriction on adult phenotypes in C57BL/6 mice depend upon a mechanism that may be independent of placental HSD2 or possibly occurs earlier in gestation.
胎盘作为生理屏障,阻止母体糖皮质激素转移到发育中的胎儿。这是通过11- β羟基类固醇脱氢酶2型酶(HSD2)氧化内源性糖皮质激素并随后使其失活来实现的。怀孕期间母体蛋白限制已被证明会导致胎盘HSD2表达减少和胎儿糖皮质激素过度暴露,特别是在妊娠后期,导致低出生体重和后代的“胎儿编程”。这种饮食干预会损害成年C57BL/6后代的胎儿生长和心血管功能,但对胎盘HSD2的影响尚未明确。本研究的目的是研究母体低蛋白饮食(18%对9%的蛋白质)对妊娠后期小鼠胎盘HSD2基因表达和酶活性的影响。与之前对大鼠的研究相反,母亲低蛋白饮食不会影响C57BL/6小鼠胎盘中HSD2蛋白或酶活性水平,这与后代的性别无关。这些数据表明,母体蛋白限制对C57BL/6小鼠成年表型的影响依赖于一种可能独立于胎盘HSD2或可能发生在妊娠早期的机制。
{"title":"Placental HSD2 Expression and Activity Is Unaffected by Maternal Protein Consumption or Gender in C57BL/6 Mice.","authors":"Mark R Garbrecht,&nbsp;Fred S Lamb","doi":"10.1155/2013/867938","DOIUrl":"https://doi.org/10.1155/2013/867938","url":null,"abstract":"The placenta acts as a physiological barrier, preventing the transfer of maternal glucocorticoids to the developing fetus. This is accomplished via the oxidation, and subsequent inactivation, of endogenous glucocorticoids by the 11-β hydroxysteroid dehydrogenase type 2 enzyme (HSD2). Maternal protein restriction during pregnancy has been shown to result in a decrease in placental HSD2 expression and fetal glucocorticoid overexposure, especially late in gestation, resulting in low birth weight and “fetal programming” of the offspring. This dietary intervention impairs fetal growth and cardiovascular function in adult C57BL/6 offspring, but the impact on placental HSD2 has not been defined. The goal of the current study was to examine the effects of a maternal low-protein diet (18% versus 9% protein) on placental HSD2 gene expression and enzyme activity in mice during late gestation. In contrast to previous studies in rats, a maternal low-protein diet did not affect HSD2 protein or enzyme activity levels in the placentas of C57BL/6 mice and this was irrespective of the gender of the offspring. These data suggest that the effects of maternal protein restriction on adult phenotypes in C57BL/6 mice depend upon a mechanism that may be independent of placental HSD2 or possibly occurs earlier in gestation.","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"867938"},"PeriodicalIF":0.0,"publicationDate":"2013-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/867938","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31518580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases. 自身免疫性甲状腺疾病中良性和恶性甲状腺结节的相关危险因素
Pub Date : 2013-05-25 Print Date: 2013-01-01 DOI: 10.1155/2013/673146
Priscila Carneiro Moreira Lima, Arnaldo Moura Neto, Marcos Antonio Tambascia, Denise Engelbrecht Zantut Wittmann

Objectives. Assess the prevalence of thyroid nodules and predictors of malignant origin in patients with autoimmune thyroid diseases. Patients and Methods. Retrospective study including 275 patients, 198 with Graves' disease and 77 with Hashimoto's thyroiditis. Clinical and demographical data, ultrasonographical nodule characteristics, total thyroid volume and histological characteristics were recorded. Results. Graves' disease: the prevalence of thyroid nodules and thyroid carcinoma were 27.78% and 5.05%, respectively. Older age (OR = 1.054; 95% CI = 1.029-1.080) and larger thyroid volumes (OR = 1.013; 95% CI = 1.003-1.022) increased the chance of nodules. Younger age (OR = 1.073; 95% CI = 1.020-1.128) and larger thyroid volume (OR = 1.018; 95% CI = 1.005-1.030) predicted thyroid carcinoma. Hashimoto's thyroiditis: the prevalence of thyroid nodules and carcinomas were 50.7% and 7.8%, respectively. Nodules were predicted by thyroid volume (OR = 1.030; 95% CI = 1.001-1.062). We found higher number of nodules in patients with thyroid carcinoma than in those with benign nodules (3 versus 2; P = 0.03). Patients with Hashimoto's thyroiditis presented nodules more frequently than patients with Graves' disease (50.65% versus 27.28%; P < 0.001), while the prevalence of carcinoma was similar (P = 0.751). Conclusions. Larger goiter was associated with carcinoma in Graves' disease and Hashimoto's thyroiditis. Younger patients presented higher risk of papillary thyroid carcinoma in Graves' disease. The prevalence of carcinoma was similar in both conditions.

目标。评估自身免疫性甲状腺疾病患者甲状腺结节的患病率和恶性起源的预测因素。患者和方法。回顾性研究包括275例患者,198例Graves病和77例桥本甲状腺炎。记录临床及人口学资料、超声结节特征、甲状腺总体积及组织学特征。结果。Graves病:甲状腺结节和甲状腺癌的患病率分别为27.78%和5.05%。年龄较大(OR = 1.054;95% CI = 1.029-1.080)和甲状腺体积增大(OR = 1.013;95% CI = 1.003-1.022)增加了结节的机会。年龄较小(OR = 1.073;95% CI = 1.020-1.128)和甲状腺体积增大(OR = 1.018;95% CI = 1.005-1.030)预测甲状腺癌。桥本甲状腺炎:甲状腺结节患病率为50.7%,甲状腺癌患病率为7.8%。甲状腺体积预测结节(OR = 1.030;95% ci = 1.001-1.062)。我们发现甲状腺癌患者的结节数量高于良性结节患者(3比2;P = 0.03)。桥本甲状腺炎患者出现结节的频率高于Graves(50.65%比27.28%;P < 0.001),而癌的患病率相似(P = 0.751)。结论。甲状腺肿大与格雷夫斯病和桥本甲状腺炎的癌相关。年轻患者患甲状腺乳头状癌的风险较高。两种情况下的癌症患病率相似。
{"title":"Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases.","authors":"Priscila Carneiro Moreira Lima,&nbsp;Arnaldo Moura Neto,&nbsp;Marcos Antonio Tambascia,&nbsp;Denise Engelbrecht Zantut Wittmann","doi":"10.1155/2013/673146","DOIUrl":"https://doi.org/10.1155/2013/673146","url":null,"abstract":"<p><p>Objectives. Assess the prevalence of thyroid nodules and predictors of malignant origin in patients with autoimmune thyroid diseases. Patients and Methods. Retrospective study including 275 patients, 198 with Graves' disease and 77 with Hashimoto's thyroiditis. Clinical and demographical data, ultrasonographical nodule characteristics, total thyroid volume and histological characteristics were recorded. Results. Graves' disease: the prevalence of thyroid nodules and thyroid carcinoma were 27.78% and 5.05%, respectively. Older age (OR = 1.054; 95% CI = 1.029-1.080) and larger thyroid volumes (OR = 1.013; 95% CI = 1.003-1.022) increased the chance of nodules. Younger age (OR = 1.073; 95% CI = 1.020-1.128) and larger thyroid volume (OR = 1.018; 95% CI = 1.005-1.030) predicted thyroid carcinoma. Hashimoto's thyroiditis: the prevalence of thyroid nodules and carcinomas were 50.7% and 7.8%, respectively. Nodules were predicted by thyroid volume (OR = 1.030; 95% CI = 1.001-1.062). We found higher number of nodules in patients with thyroid carcinoma than in those with benign nodules (3 versus 2; P = 0.03). Patients with Hashimoto's thyroiditis presented nodules more frequently than patients with Graves' disease (50.65% versus 27.28%; P < 0.001), while the prevalence of carcinoma was similar (P = 0.751). Conclusions. Larger goiter was associated with carcinoma in Graves' disease and Hashimoto's thyroiditis. Younger patients presented higher risk of papillary thyroid carcinoma in Graves' disease. The prevalence of carcinoma was similar in both conditions.</p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"673146"},"PeriodicalIF":0.0,"publicationDate":"2013-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/673146","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31502717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
The effect of pioglitazone on antioxidant levels and renal histopathology in streptozotocin-induced diabetic rats. 吡格列酮对链脲佐菌素诱导的糖尿病大鼠抗氧化水平及肾脏组织病理学的影响。
Pub Date : 2013-05-09 Print Date: 2013-01-01 DOI: 10.1155/2013/858690
Munire Kuru Karabas, Mediha Ayhan, Engin Guney, Mukadder Serter, Ibrahim Meteoglu

Objective. Diabetic nephropathy is the most commonly seen cause of chronic renal failure, and oxidative stress is important in etiology. In the present study, favorable effects (if any) of the treatment with a thiazolidinedione group drug, pioglitazone, on antioxidant enzyme levels in the renal tissue, renal histopathology, and inflammatory cytokine levels have been investigated. Method. Forty male Wistar rats were divided into 4 groups as the control, diabetic control, and 10 and 30 mg pioglitazone-administered diabetic groups. After 4 weeks, antioxidant enzyme levels in renal tissues and inflammatory markers were investigated. Results. Blood glucose levels did not differ between the diabetic control and drug-administered groups. In pioglitazone-administered rats, histopathological findings such as tubular dilation, necrotic tubular epithelium, glomerular focal necrosis, and vascular consolidation were observed at a lesser extent than the diabetic control group. Any difference was not detected between the diabetic groups with respect to the levels of malondialdehyde, superoxide dismutase, catalase, glutathione, nitric oxide, interleukin-6, and tumor necrosis factor-alpha. Conclusion. Pioglitazone regressed development of histopathological lesions such as glomerular focal necrosis, tubular epithelial necrosis, tubular dilation, and vascular wall consolidation. However, any favorable effect on antioxidant enzyme levels in renal tissues and inflammation markers was not detected.

目标。糖尿病肾病是慢性肾功能衰竭最常见的病因,氧化应激在病因学中占有重要地位。在本研究中,研究了噻唑烷二酮类药物吡格列酮对肾脏组织中抗氧化酶水平、肾脏组织病理学和炎症细胞因子水平的有利影响(如果有的话)。方法。将40只雄性Wistar大鼠分为4组,分别为对照组、糖尿病对照组和吡格列酮给药10、30 mg糖尿病组。4周后,观察肾脏组织抗氧化酶水平和炎症标志物。结果。血糖水平在糖尿病对照组和药物组之间没有差异。在吡格列酮给药的大鼠中,观察到的组织病理学结果,如小管扩张、小管上皮坏死、肾小球局灶性坏死和血管实变的程度低于糖尿病对照组。糖尿病组之间在丙二醛、超氧化物歧化酶、过氧化氢酶、谷胱甘肽、一氧化氮、白细胞介素-6和肿瘤坏死因子- α的水平方面没有发现任何差异。结论。吡格列酮可延缓组织病理学病变的发展,如肾小球局灶性坏死、小管上皮坏死、小管扩张和血管壁实变。然而,未发现对肾组织抗氧化酶水平和炎症标志物有任何有利影响。
{"title":"The effect of pioglitazone on antioxidant levels and renal histopathology in streptozotocin-induced diabetic rats.","authors":"Munire Kuru Karabas,&nbsp;Mediha Ayhan,&nbsp;Engin Guney,&nbsp;Mukadder Serter,&nbsp;Ibrahim Meteoglu","doi":"10.1155/2013/858690","DOIUrl":"https://doi.org/10.1155/2013/858690","url":null,"abstract":"<p><p>Objective. Diabetic nephropathy is the most commonly seen cause of chronic renal failure, and oxidative stress is important in etiology. In the present study, favorable effects (if any) of the treatment with a thiazolidinedione group drug, pioglitazone, on antioxidant enzyme levels in the renal tissue, renal histopathology, and inflammatory cytokine levels have been investigated. Method. Forty male Wistar rats were divided into 4 groups as the control, diabetic control, and 10 and 30 mg pioglitazone-administered diabetic groups. After 4 weeks, antioxidant enzyme levels in renal tissues and inflammatory markers were investigated. Results. Blood glucose levels did not differ between the diabetic control and drug-administered groups. In pioglitazone-administered rats, histopathological findings such as tubular dilation, necrotic tubular epithelium, glomerular focal necrosis, and vascular consolidation were observed at a lesser extent than the diabetic control group. Any difference was not detected between the diabetic groups with respect to the levels of malondialdehyde, superoxide dismutase, catalase, glutathione, nitric oxide, interleukin-6, and tumor necrosis factor-alpha. Conclusion. Pioglitazone regressed development of histopathological lesions such as glomerular focal necrosis, tubular epithelial necrosis, tubular dilation, and vascular wall consolidation. However, any favorable effect on antioxidant enzyme levels in renal tissues and inflammation markers was not detected.</p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"858690"},"PeriodicalIF":0.0,"publicationDate":"2013-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/858690","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31502718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Effect of polyherbal mixtures on the treatment of diabetes. 中药复方治疗糖尿病的疗效观察。
Pub Date : 2013-04-16 Print Date: 2013-01-01 DOI: 10.1155/2013/934797
Aparajeya Panda, Somanatha Jena, Pramod Kumar Sahu, Sanghamitra Nayak, Payodhar Padhi

The study focuses on polyherbal antidiabetic formulations of different plants used in the treatment of diabetes mixed in different concentrations. In the present study eleven medicinal plants with proven antidiabetic and related beneficial effects were selected for the preparation of five mixtures. The efficacy of prepared mixtures has been tested on streptozotocin- (STZ-) induced diabetic rats and compared with a commercially available drug glibenclamide. The mixtures at the dose levels of 400 mg/kg b.w. produced a significant decrease in blood glucose level by 69.6%, 70.97%, 64.45%, 71.82%, and 64.44% after 21 days of treatment. The elevated level of SGPT, SGOT, and ALP in the diabetic controlled group reflected the significant alteration of liver function by STZ induction and was found to be equipotent to glibenclamide in restoration of the elevated enzyme levels to normal. The elevated lipid levels (triglyceride and total cholesterol) were restored to near normal by these mixtures for all the estimated parameters. The results of the mixtures on treated group were found to restore the glycemic level to the near normal level thereby indicating antihyperglycemic activity of the formulated mixtures.

本研究的重点是不同植物以不同浓度混合治疗糖尿病的多药抗糖尿病配方。本研究选取了11种经证实具有抗糖尿病及相关有益作用的药用植物,制备了5种合剂。制备的混合物对链脲佐菌素(STZ-)诱导的糖尿病大鼠进行了疗效试验,并与市售药物格列本脲进行了比较。在400 mg/kg b.w.的混合剂量下,治疗21 d后血糖水平分别下降了69.6%、70.97%、64.45%、71.82%和64.44%。糖尿病对照组SGPT、SGOT和ALP水平的升高反映了STZ诱导的肝功能的显著改变,并被发现在将升高的酶水平恢复到正常水平方面与格列本脲具有同等效力。高脂水平(甘油三酯和总胆固醇)被这些混合物恢复到接近正常的所有估计参数。结果发现,治疗组的混合物将血糖水平恢复到接近正常水平,从而表明配制混合物的抗高血糖活性。
{"title":"Effect of polyherbal mixtures on the treatment of diabetes.","authors":"Aparajeya Panda,&nbsp;Somanatha Jena,&nbsp;Pramod Kumar Sahu,&nbsp;Sanghamitra Nayak,&nbsp;Payodhar Padhi","doi":"10.1155/2013/934797","DOIUrl":"https://doi.org/10.1155/2013/934797","url":null,"abstract":"<p><p>The study focuses on polyherbal antidiabetic formulations of different plants used in the treatment of diabetes mixed in different concentrations. In the present study eleven medicinal plants with proven antidiabetic and related beneficial effects were selected for the preparation of five mixtures. The efficacy of prepared mixtures has been tested on streptozotocin- (STZ-) induced diabetic rats and compared with a commercially available drug glibenclamide. The mixtures at the dose levels of 400 mg/kg b.w. produced a significant decrease in blood glucose level by 69.6%, 70.97%, 64.45%, 71.82%, and 64.44% after 21 days of treatment. The elevated level of SGPT, SGOT, and ALP in the diabetic controlled group reflected the significant alteration of liver function by STZ induction and was found to be equipotent to glibenclamide in restoration of the elevated enzyme levels to normal. The elevated lipid levels (triglyceride and total cholesterol) were restored to near normal by these mixtures for all the estimated parameters. The results of the mixtures on treated group were found to restore the glycemic level to the near normal level thereby indicating antihyperglycemic activity of the formulated mixtures.</p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"934797"},"PeriodicalIF":0.0,"publicationDate":"2013-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/934797","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31538621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
期刊
ISRN endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1